- Previous Close
39,650.00 - Open
38,400.00 - Bid 40,850.00 x --
- Ask 40,900.00 x --
- Day's Range
38,400.00 - 40,950.00 - 52 Week Range
32,550.00 - 47,000.00 - Volume
56,694 - Avg. Volume
20,957 - Market Cap (intraday)
767.473B - Beta (5Y Monthly) 0.94
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 14, 2025 - May 19, 2025
- Forward Dividend & Yield 1,700.00 (4.29%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
SK Discovery Co., Ltd., through its subsidiaries, engages in environmental friendly materials, vaccines/pharmaceuticals, energy/chemicals, and real estate development businesses in South Korea and internationally. The company offers environmental friendly materials and healthcare solutions in the areas of treatment, prevention, and diagnosis to patients. It also engages in the storage of LPG; tank terminal; and power generation business, as well as real estate development of commercial facilities, office buildings, hotels, urban housings, luxury housings, and renewable energy generation facilities, such as solar and wind power generation. The company was formerly known as SK Chemicals Co., Ltd. and changed its name to SK Discovery Co., Ltd. in December 2017. SK Discovery Co., Ltd. was founded in 1969 and is based in Seongnam-si, South Korea.
www.skdiscovery.comRecent News: 006120.KS
View MorePerformance Overview: 006120.KS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 006120.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 006120.KS
View MoreValuation Measures
Market Cap
744.93B
Enterprise Value
4.74T
Trailing P/E
30.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.09
Price/Book (mrq)
0.27
Enterprise Value/Revenue
0.52
Enterprise Value/EBITDA
8.04
Financial Highlights
Profitability and Income Statement
Profit Margin
0.28%
Return on Assets (ttm)
0.79%
Return on Equity (ttm)
0.51%
Revenue (ttm)
9.04T
Net Income Avi to Common (ttm)
25.19B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
2.5T
Total Debt/Equity (mrq)
100.58%
Levered Free Cash Flow (ttm)
-704.25B